Guru Ownership Trend
Guru Analysis for Maze Therapeutics, Inc. (MAZE)
Maze Therapeutics, Inc. (MAZE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.07 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.32 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 1.8%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 41.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Maze Therapeutics, Inc. (MAZE)
Major holders include Cliff Asness ($834,158), Renaissance Technologies (RenTech) ($471,630). According to the latest reported data, 2 tracked investment managers collectively hold approximately 43,745 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.32 M, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited MAZE. The total reported sell value was $1.33 M.
Yes, 0 managers opened new positions in MAZE, and 1 increased their existing holdings. The total reported buy value was $15,104.1.